Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Jul 14;10(7):e0132036.
doi: 10.1371/journal.pone.0132036. eCollection 2015.

Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis

Chao Lu et al. PLoS One. .

Abstract

Background: There is no consensus on the vitamin D levels and inflammatory bowel disease (IBD).

Aim: To conduct a systematic review and meta-analysis to analyze the relationship between IBD and 25(OH)D, sun exposure, and latitude, and to determine whether vitamin D deficiency affects the severity of IBD.

Methods: We searched the PubMed, EBSCO, and ClinicalTrials.gov databases to identify all studies that assessed the association between 25(OH)D, sun exposure, latitude, and IBD through November 1, 2014, without language restrictions. Studies that compared 25(OH)D levels between IBD patients and controls were selected for inclusion in the meta-analysis. We calculated pooled standardized mean differences (SMDs) and odds ratios (ORs).

Results: Thirteen case-control studies investigating CD and 25(OH)D levels were included, and eight studies part of above studies also investigated the relationship between UC and 25(OH)D. Both CD patients (SMD: 0.26 nmol/L, 95% confidence interval [CI]: 0.09-0.42 nmol/L) and UC patients (SMD: 0.5 nmol/L, 95% CI: 0.15-0.85 nmol/L) had lower levels of 25(OH)D than controls. In addition, CD patients and UC patients were 1.95 times (OR, 1.95; 95% CI, 1.48-2.57) and 2.02 times (OR, 2.02; 95% CI, 1.13-3.60) more likely to be 25(OH)D deficient than controls. We also included 10 studies investigating the relationship between CD activity and vitamin D. Results showed that patients with active CD (CD Activity Index ≥ 150) were more likely to have low vitamin D levels. In addition, whether low sun exposure and high latitude were related to a high morbidity of CD need to be provided more evidence.

Conclusion: Our study shows that IBD patients have lower vitamin D levels. For active CD patients, vitamin D levels were low. These findings suggest that vitamin D may play an important role in the development of IBD, although a direct association could not be determined in our study.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow diagram of searching.
Fig 2
Fig 2. Meta-analysis of studies reporting 25(OH)D levels in CD patients vs. controls, a standardized mean difference with a 95% confidence interval and weight percentage.
Subtotals of adults and children, and overall population.
Fig 3
Fig 3. Meta-analysis of studies reporting 25(OH)D levels in UC patients vs. controls, a standardized mean difference with a 95% confidence interval and weight percentage.
Subtotals of adults and children, and overall population.
Fig 4
Fig 4. Meta-analysis of studies reporting dichotomous outcomes of 25(OH)D levels in CD patients vs. controls and estimated OR with a 95% confidence interval and weight percentage.
Fig 5
Fig 5. Egger’s test results for publication bias about dichotomous outcomes of 25(OH)D levels in CD.
Fig 6
Fig 6. Meta-analysis of studies reporting dichotomous outcomes of 25(OH)D levels in UC patients vs. controls and estimated OR with a 95% confidence interval and weight percentage.

Similar articles

Cited by

References

    1. Abraham C, Cho JH. Inflammatory bowel disease. The New England journal of medicine. 2009;361(21):2066–78. Epub 2009/11/20. 10.1056/NEJMra0804647 - DOI - PMC - PubMed
    1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504–17. Epub 2004/05/29. . - PubMed
    1. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603–6. Epub 2001/06/01. 10.1038/35079114 . - DOI - PubMed
    1. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (New York, NY). 2006;314(5804):1461–3. Epub 2006/10/28. 10.1126/science.1135245 . - DOI - PMC - PubMed
    1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature reviews Immunology. 2003;3(7):521–33. Epub 2003/07/24. 10.1038/nri1132 . - DOI - PubMed

LinkOut - more resources